BioCentury
ARTICLE | Company News

Opiant gets rights to Aegis' Intravail delivery tech

July 7, 2017 8:43 PM UTC

Addiction and eating disorder company Opiant Pharmaceuticals Inc. (OTCQB:OPNT) received rights to use the Intravail drug delivery system from Aegis Therapeutics LLC (San Diego, Calif.). The license covers all of Opiant's opioid antagonists...